Application of Novel Ethylene Bridged Hybrid Particles for Hydrophilic-Interaction Chromatography

Article

The Application Notebook

The Application NotebookThe Application Notebook-02-01-2009
Volume 0
Issue 0

Using HILIC with highly efficient ethylene bridged hybrid (BEH) particles results in faster methods that exhibit improved polar retention, higher sensitivity, enhanced chromatographic resolution, and significantly improved column lifetime.

Using HILIC with highly efficient ethylene bridged hybrid (BEH) particles results in faster methods that exhibit improved polar retention, higher sensitivity, enhanced chromatographic resolution, and significantly improved column lifetime.

Hydrophilic-interaction chromatography (HILIC) is a chromatographic technique that improves the retention of very polar species that are poorly retained in reversed-phase HPLC (RP–HPLC) by using a high organic, low aqueous mobile phase in combination with a polar stationary phase.

HILIC offers several benefits over RP–HPLC with regards to MS response and simplification of sample preparation methods.

Experimental

Separations were performed on a Waters ACQUITY UPLC system. Detection was performed with an ACQUITY TQD mass spectrometer in SIR mode (m/z 146.2 for acetylcholine and m/z 103.9 for choline).

Results

Comparison of ESI+ MS response in HILIC- and RP–UPLC for (1) acetylcholine and (2) choline is shown in Figure 1. Direct injection of an SPE eluate (5% NH4OH in ACN) from an Oasis MCX μElution plate (PN 186001830BA) onto an XBridge HILIC column (2.1 × 100 mm, 3.5 μm, PN 186004433) is shown in Figure 2.

Figure 1: Increased MS signal intensity with HILIC.

Conclusions

Novel BEH particles were found to be useful for HILIC separations and exhibit chemical resistance superior to that of silica particles at moderate pH over the course of 2000 injections. HILIC offers complementary selectivity to RP and was found to yield up to 10-fold improvement in ESI-MS response when compared to RP-HPLC. Separations are directly transferable between XBridge HILIC and ACQUITY UPLC BEH HILIC columns.

Figure 2: Direct injection of extracted opiates from spiked human plasma.

For the complete UPLC application note, visit www.waters.com/27111.

© 2008 Waters Corporation. Waters, The Science of What's Possible, UPLC, ACQUITY UPLC, ACQUITY, XBridge and Oasis are trademarks of Waters Corporation.

Waters Corporation

34 Maple Street, Milford, MA 01757

tel. (508)478-2000, fax (508)478-1990

Website: www.waters.com

Related Content